V

Velocity Clinical Research

Operates multi-site clinical trial network

Principal Investigator

Physicians & SurgeonsConfirmed live in the last 24 hours
Part-timeRhode Island, USANo salary listed

About the Job

Requirements

  • Understanding of regulatory requirements, principles of Good Clinical Practice, and biomedical research ethics.
  • Ability to communicate effectively in a flexible and collaborative manner.
  • Critical thinking, dynamic problem-solving skills, and attention to detail.
  • Ability to travel for work-related purposes, up to 10% as needed for project team meetings, client presentations, and other professional meetings or conferences.
  • Minimum qualification of an M.D. or D.O. with an active medical license valid in the state where the research is conducted.
  • Training and certification in Good Clinical Practice.
  • Board certification or board eligibility in a specialty appropriate to the type of research conducted at the site.
  • Training and certification in Velocity-required trainings and Standard Operating Procedures.

Responsibilities

  • Provide overall medical direction and medical review of protocols in conformance with the investigational plan and Good Clinical Practice.
  • Provide medical expertise and scientific feasibility assessments for new sponsor inquiries.
  • Ensure the safety and well-being of all study participants at the trial site.
  • Ensure data collected at the study site is credible and accurate.
  • Protect the rights, integrity, and confidentiality of all trial participants at the site.
  • Assist and provide guidance to clinical operations, research staff, and sponsor client managers as required.
  • Obtain and/or review participants’ medical histories.
  • Perform physical assessments, examinations, and study procedures as required by study protocols.
  • Evaluate and interpret clinical data and diagnostic information, including X-rays, ECGs, and laboratory work.
  • Immediately report Serious Adverse Events or any abnormalities affecting participant safety to sponsors and the IRB as required by study-specific reporting guidelines.
  • Oversee administration of the investigational product.
  • Review and adhere to the study protocol.
  • Maintain proper documentation.
  • Ensure reported data is accurate, complete, legible, timely, and consistent with source documents.
  • Before starting a study and while it is ongoing, ensure the study, clinical trial protocol, informed consent form, recruitment materials, and other documents provided to participants are approved by the IRB and comply with Good Clinical Practice and applicable regulatory requirements.
  • Ensure the IRB receives a copy of the Investigator’s Brochure, product monograph, or information about the product or intervention being studied so the IRB can assess the risks involved.
  • During the study, ensure the IRB is informed of changes to the protocol, Investigator’s Brochure or other safety information about the product or intervention, protocol deviations, and unanticipated problems.
  • Maintain thorough familiarity with the appropriate use of the investigational product as described in the protocol, Investigator’s Brochure or product monograph, and other sponsor-provided documents.
  • Comply with International Council for Harmonisation Good Clinical Practice and all applicable regulatory requirements.
  • Maintain trial documents as specified by guidelines and applicable regulatory requirements.
  • Retain essential documents until at least two years after the last approval of a marketing application or at least two years after formal discontinuation of the investigational product.
  • Participate in monitoring visits and sponsor meetings; permit monitoring and auditing by sponsors and inspection by appropriate regulatory agencies.
  • Provide research-related records to monitors, auditors, IRB representatives, and regulatory authorities.
  • Ensure participants are informed and receive appropriate therapy and follow-up if the trial is prematurely terminated or suspended.
  • Inform the IRB, and the study sponsor when the investigator terminates a trial without prior agreement, and provide a detailed written explanation of the trial’s termination or suspension.

About the Company

Velocity Clinical Research

Operates multi-site clinical trial network

Velocity Clinical Research operates the world’s largest network of fully integrated clinical research sites, with 70+ sites and 200+ investigators, collaborating with pharmaceutical and biotechnology companies to study new drugs, medical devices, diagnostics, and combination products. Its unified site solutions connect the right patients, investigators, and research staff across the U.S. and Europe, enabling efficient trial execution. A technology hub in India develops systems that leverage site, patient, and historical performance data to improve operations. The company’s approach centers on delivering high-quality data, excellent patient care, and greater efficiency for clinical trials at any scale. Its differentiators include a broad, integrated site network, global reach, and a focus on data-driven processes to speed research while maintaining quality.

Company size
1,001-5,000
Company stage
Not listed
Total funding
Not listed
Headquarters
Cincinnati, OH
Founded
1999

Recently Posted Jobs

Explore more opportunities at Velocity Clinical Research

See more jobs